Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
We are pleased to announce that Thermo Fisher Scientific and global biotechnology company CSL have entered into a strategic partnership to help meet the growing demand for biologic therapies while also accelerating CSL’s broader manufacturing objectives. As part of the partnership, Thermo Fisher will operate a new state-of-the-art biologics manufacturing facility in Lengnau, Switzerland, when construction is completed in mid-2021. Please watch this video to learn more about this exciting partnership.